Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors

2008 ◽  
Vol 16 (18) ◽  
pp. 8627-8634 ◽  
Author(s):  
Kenichi Onda ◽  
Ryota Shiraki ◽  
Yasuhiro Yonetoku ◽  
Kazuhiro Momose ◽  
Naoko Katayama ◽  
...  
2017 ◽  
Vol 24 (4) ◽  
pp. 384-403 ◽  
Author(s):  
Demetres Leonidas ◽  
Joseph Hayes ◽  
Atsushi Kato ◽  
Vassiliki Skamnaki ◽  
Demetra Chatzileontiadou ◽  
...  

2005 ◽  
Vol 14 (7) ◽  
pp. 1760-1771 ◽  
Author(s):  
Nikos G. Oikonomakos ◽  
Magda N. Kosmopoulou ◽  
Evangelia D. Chrysina ◽  
Demetres D. Leonidas ◽  
Ioannis D. Kostas ◽  
...  

2013 ◽  
Vol 23 (8) ◽  
pp. 1017-1032 ◽  
Author(s):  
Nicolas Gaboriaud-Kolar ◽  
Alexios-Leandros Skaltsounis

2021 ◽  
pp. 00-00
Author(s):  
Youde Wang ◽  
Zhiwei Yan ◽  
Yachun Guo ◽  
Liying Zhang

Glycogen phosphorylase (GP) is a key enzyme of glycogen catabolism, so it is significant to discover a new GP inhibitor. A series of benzazepinone derivatives were discovered as GP inhibitors with potent activity. Among these derivatives, compound 5d showed significant potential against rabbit muscle GPa (IC50 = 0.25 ± 0.05 μM) and cellular efficacy. The in vivo study revealed that 5d significantly inhibited increases in fasting blood glucose level in two kinds of hyperglycemic mice models. The possible binding mode of compound 5d was explored based on molecular docking simulations. These results indicated that derivatives with benzazepinone were potential chemical entities against hyperglycemia.


Biochemistry ◽  
2008 ◽  
Vol 47 (16) ◽  
pp. 4683-4691 ◽  
Author(s):  
Oliver Anderka ◽  
Petra Loenze ◽  
Thomas Klabunde ◽  
Matthias K. Dreyer ◽  
Elisabeth Defossa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document